The Imaging of Apoptosis with the Radiolabeled annexin V: Optimal Timing for Clinical Feasibility

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Technology in Cancer Research and Treatment

• Publication date

  2004-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/153303460400300103PMID 14750890
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preparation of F-18 labeled annexin V: a potential PET radiopharmaceutical for imaging cell death.

  2004cited by this paper
• Imaging taxane-induced tumor apoptosis using PEGylated, 111In-labeled annexin V.

  2004cited by this paper
• 18F-labelled annexin V: a PET tracer for apoptosis imaging

  2004cited by this paper
• Synthesis and evaluation of a 18F-labelled recombinant annexin-V derivative, for identification and quantification of apoptotic cells with PET.

  2003cited by this paper
• Optimization of the preparation of 99mTc-labeled Hynic-derivatized Annexin V for human use.

  2003cited by this paper
• "Targets for cancer chemotherapy: transcriptions factors and other nuclear proteins" (eds. N. B. L. Thangue i L. R. Bandara)

  2003cited by this paper
• Delayed expression of apoptosis in human lymphoma cells undergoing low-dose taxol-induced mitotic stress

  2003cited by this paper
• A simplified method for preparation of 99mTc-annexin V and its biologic evaluation for in vivo imaging of apoptosis after photodynamic therapy.

  2003cited by this paper
• Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.

  2003cited by this paper
• Improved Radiolabeling of PEGylated Protein: PEGylated Annexin V for Noninvasive Imaging of Tumor Apoptosis

  2003cited by this paper
• [18F]FDG PET monitoring of tumour response to chemotherapy: does [18F]FDG uptake correlate with the viable tumour cell fraction?

  2003cited by this paper
• Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-annexin V.

  2003cited by this paper
• Iodine-124 labelled annexin-V as a potential radiotracer to study apoptosis using positron emission tomography.

  2003cited by this paper
• Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging.

  2003cited by this paper
• Quantitative tumor apoptosis imaging using technetium-99m-HYNIC annexin V single photon emission computed tomography.

  2003cited by this paper
• The Role of the Macrophage in Apoptosis: Hunter, Gatherer, and Regulator

  2002cited by this paper
• To scan or not to scan, it is a question of timing: technetium-99m-annexin V radionuclide imaging assessment of treatment efficacy after one course of chemotherapy.

  2002cited by this paper
• Clinical trial design for target-based therapy.

  2002cited by this paper
• Increased exposure of anionic phospholipids on the surface of tumor blood vessels.

  2002cited by this paper
• Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis.

  2002cited by this paper
• Translating basic cancer research into new cancer therapeutics.

  2002cited by this paper
• Monitoring apoptosis in real time.

  2002cited by this paper
• Advancing animal models of neoplasia through in vivo bioluminescence imaging.

  2002cited by this paper
• Iodination of annexin V for imaging apoptosis.

  2002cited by this paper
• Challenges of PK/PD measurements in modern drug development.

  2002cited by this paper
• Targets for cancer chemotherapy : transcription factors and other nuclear proteins

  2002cited by this paper
• Imaging cyclophosphamide-induced intramedullary apoptosis in rats using 99mTc-radiolabeled annexin V.

  2001cited by this paper
• Biodistribution and dosimetry of 99mTc-BTAP-annexin-V in humans

  2001cited by this paper
• Synthesis and in vitro evaluation of 123I-labelled human recombinant annexin V.

  2001cited by this paper
• Early stages of p53-induced apoptosis are reversible

  2001cited by this paper
• In Vivo and In Vitro Measurement of Apoptosis in Breast Cancer Cells Using 99mTc-EC-Annexin V

  2001cited by this paper
• Apoptosis in squamous cell carcinoma of the lung: correlation with survival and clinicopathological features

  2001cited by this paper
• Biodistribution and dosimetry of (99m)Tc-BTAP-annexin-V in humans.

  2001cited by this paper
• Apoptosis and the response to anticancer therapy

  2001cited by this paper
• Apoptosis: The importance of nuclear medicine

  2000cited by this paper
• Development and characterization of annexin V mutants with endogenous chelation sites for (99m)Tc.

  2000cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors

  2000cited by this paper
• Paclitaxel-induced apoptosis and mitotic arrest assessed by serial fine-needle aspiration: implications for early prediction of breast cancer response to neoadjuvant treatment.

  2000cited by this paper
• Immunologic Stimulation of Mast Cells Leads to the Reversible Exposure of Phosphatidylserine in the Absence of Apoptosis

  2000cited by this paper
• Apoptosis in cancer.

  2000cited by this paper
• Apoptotic cell death: its implications for imaging in the next millennium

  2000cited by this paper
• [New guidelines to evaluate the response to treatment in solid tumors].

  2000cited by this paper
• Induction of apoptosis by cancer chemotherapy.

  2000cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

  2000cited by this paper
• Use of reporter genes for optical measurements of neoplastic disease in vivo.

  2000cited by this paper
• Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death.

  1999cited by this paper
• Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications.

  1999cited by this paper
• Imaging of apoptosis (programmed cell death) with 99mTc annexin V.

  1999cited by this paper
• Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis

  1999cited by this paper
• Apoptosis: programmed cell death.

  1998cited by this paper
• Dysregulation of apoptosis in cancer.

  1998cited by this paper
• Pharmacodynamics of immediate and delayed effects of paclitaxel: role of slow apoptosis and intracellular drug retention.

  1998cited by this paper
• In vivo detection and imaging of phosphatidylserine expression during programmed cell death.

  1998cited by this paper
• Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate.

  1998cited by this paper
• Pathophysiologic implications of membrane phospholipid asymmetry in blood cells.

  1997cited by this paper
• Methods utilized in the study of apoptosis.

  1997cited by this paper
• Apoptosis in cancer.

  1996cited by this paper
• Tumor type is a determinant of susceptibility to apoptosis.

  1995cited by this paper
• Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl

  1995cited by this paper
• Formation of two-dimensional arrays of annexin V on phosphatidylserine-containing liposomes.

  1994cited by this paper
• Apoptosis. Its significance in cancer and cancer Therapy

  1994cited by this paper
• Relationship between annexin V tryptophan exposure, calcium, and phospholipid binding.

  1993cited by this paper
• Apoptosis induced by anticancer drugs

  1992cited by this paper
• Crystal and molecular structure of human annexin V after refinement. Implications for structure, membrane binding and ion channel formation of the annexin family of proteins.

  1992cited by this paper
• Induction of apoptosis--new targets for cancer chemotherapy.

  1992cited by this paper
• Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages.

  1992cited by this paper
• Bidirectional transbilayer movement of phospholipid analogs in human red blood cells. Evidence for an ATP-dependent and protein-mediated process.

  1992cited by this paper
• Transbilayer movement of phospholipids in red cell and platelet membranes.

  1991cited by this paper
• Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics

  1972cited by this paper

• First-in-human study of a novel cell death tracer [99mTc]Tc-Duramycin: safety, biodistribution and radiation dosimetry in healthy volunteers

  2023cites this paper
• Exploratory window‐of‐opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer

  2021cites this paper
• Detection of Apoptosis: From Bench Side to Clinical Practice

  2016cites this paper
• Apoptosis Methods in Toxicology

  2016cites this paper
• [18F]ML-10 PET: Initial Experience in Glioblastoma Multiforme Therapy Response Assessment

  2016cites this paper
• Computer Aided Theragnosis Using Quantitative Ultrasound Spectroscopy and Maximum Mean Discrepancy in Locally Advanced Breast Cancer

  2016cites this paper
• 99mTc-Annexin A5 quantification of apoptotic tumor response: a systematic review and meta-analysis of clinical imaging trials

  2015cites this paper
• PET imaging of apoptosis in tumor-bearing mice and rabbits after paclitaxel treatment with (18)F(-)Labeled recombinant human His10-annexin V.

  2015cites this paper
• Quantitative evaluation of cell death response in vitro and in vivo using conventional-frequency ultrasound

  2015cites this paper
• Cancer therapy prognosis using quantitative ultrasound spectroscopy and a kernel-based metric

  2014cites this paper
• Site-specifically 11C-labeled Sel-tagged annexin A5 and a size-matched control for dynamic in vivo PET imaging of protein distribution in tissues prior to and after induced cell death.

  2013cites this paper
• Site-speci fi cally 11 C-labeled Sel-tagged annexin A 5 and a size-matched control for dynamic in vivo PET imaging of protein distribution in tissues prior to and after induced cell death

  2013cites this paper
• Radiopharmaceuticals for Imaging in Oncology with Special Emphasis on Positron-Emitting Agents

  2013cites this paper
• Applications of f low cytometry in healthcare: An update

  2013cites this paper
• Assessment of Response to Therapy

  2012cites this paper
• Targeted Nuclear Imaging of Breast Cancer: Status of Radiotracer Development and Clinical Applications

  2012cites this paper
• Specific biomarkers of receptors, pathways of inhibition and targeted therapies: pre-clinical developments.

  2011cites this paper
• Molecular imaging in cancer treatment

  2011cites this paper
• Preclinical Imaging of Therapy Response Using Metabolic and Apoptosis Molecular Imaging

  2011cites this paper
• Apoptosis In Vivo

  2011cites this paper
• Site-specific 68Ga-labeled Annexin A5 as a PET imaging agent for apoptosis.

  2011cites this paper
• Site-specific labeling of 'second generation' annexin V with 99mTc(CO)3 for improved imaging of apoptosis in vivo.

  2010cites this paper
• Time Course of Paclitaxel-Induced Apoptosis in an Experimental Model of Virus-Induced Breast Cancer

  2010cites this paper
• Potential use of ultrasound for the detection of cell changes in cancer treatment.

  2009cites this paper
• Molecular imaging of apoptosis with radio-labeled Annexin A5 focused on the evaluation of tumor response to chemotherapy.

  2009cites this paper
• APOMAB®, a La-Specific Monoclonal Antibody, Detects the Apoptotic Tumor Response to Life-Prolonging and DNA-Damaging Chemotherapy

  2009cites this paper
• Immunotargeting of Functional Nanoparticles for MRI detection of Apoptotic Tumor Cells

  2009cites this paper
• Translational imaging: imaging of apoptosis.

  2008cites this paper
• Monitoring of treatment-induced apoptosis in oncology with PET and SPECT.

  2008cites this paper
• In Vivo Detection of Apoptosis

  2008influential citation
• 99mTc-HYNIC-rh-annexin-V scintigraphy: visual and quantitative evaluation of early treatment-induced apoptosis to predict treatment outcome

  2008cites this paper
• Imaging of Apoptosis

  2007cites this paper
• PET imaging of apoptosis with 64Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V

  2007cites this paper
• Mapping of treatment-induced apoptosis in normal structures: 99mTc-Hynic-rh-annexin V SPECT and CT image fusion

  2006cites this paper
• Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn’s disease

  2006cites this paper
• The imaging of apoptosis with the radiolabelled annexin A5: a new tool in translational research.

  2006cites this paper
• A fluorescent nanosensor for apoptotic cells.

  2006cites this paper
• Definition of Target Volume and Organs at Risk. Biological Target Volume

  2006cites this paper
• To use MIBI or not to use MIBI? That is the question when assessing tumour cells

  2005cites this paper
• Biological imaging in radiation oncology.

  2005cites this paper
• Positron Emission Tomography for Radiation Treatment Planning

  2005cites this paper
• Methotrexate-Induced Accumulation of Fluorescent Annexin V in Collagen-Induced Arthritis

  2005cites this paper
• IDENTIFICATION, ISOLATION, CLONING AND SEQUENCING APARTIALANNEXIN GENE FROM AUREOBASIDIUM PULLULANS

  2005cites this paper
• Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors

  2005cites this paper
• In vivo imaging of apoptosis by 99mTc-Annexin V scintigraphy: visual analysis in relation to treatment response.

  2004cites this paper
• Oncological molecular imaging: nuclear medicine techniques.

  2003cites this paper